Neogenomics (NEO) EBIT (2010 - 2026)
Neogenomics' (NEO) quarterly EBIT came in at -$9.8 million in Q2 2026, up 79.48% YoY from -$5.4 million in Q2 2025, and up 46.43% on a QoQ basis from -$18.2 million in Q1 2026.
Neogenomics (NEO) EBIT (2010 - 2026) Analysis & Trends
Neogenomics (NEO) has 17 years of EBIT data on file, last reported at -$9.8 million in Q2 2026.
- Quarterly EBIT rose 79.48% year-over-year to -$9.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$68.4 million (up 40.51% YoY) and the FY2025 annual result came in at -$115.9 million, down 25.81% from the prior year.
- EBIT advanced to -$9.8 million in Q2 2026, from -$18.2 million in the prior quarter.
- In the past five years, EBIT ranged from a high of -$9.8 million in Q2 2026 to a low of -$52.0 million in Q1 2022.
- A 5-year average of -$27.9 million and a median of -$26.7 million in 2022 frame the typical range for EBIT.
- Annual changes were most pronounced in 2022 — EBIT slumped 244.4% — and 2026, when it surged 79.48%.
- Tracing NEO's EBIT over 5 years: stood at -$26.4 million in 2022, then grew by 29.6% to -$18.6 million in 2023, then grew by 0.93% to -$18.4 million in 2024, then grew by 27.1% to -$13.4 million in 2025, then increased by 27.16% to -$9.8 million in 2026.
- The last three EBIT figures came in at -$9.8 million (Q2 2026), -$18.2 million (Q1 2026), and -$13.4 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.77 Bn | 209.71 Bn | 8.34 Bn | 2.09 Bn |
| 2 | Danaher | 139.78 Bn | 135.43 Bn | 3.61 Bn | 1.13 Bn |
| 3 | Idexx Laboratories | 46.04 Bn | 45.85 Bn | 779.09 Mn | 425.57 Mn |
| 4 | Agilent Technologies | 39.68 Bn | 37.88 Bn | 990.00 Mn | 399.00 Mn |
| 5 | Iqvia Holdings | 39.34 Bn | 37.26 Bn | 1.44 Bn | 506.00 Mn |
| 6 | Natera | 38.75 Bn | 37.65 Bn | 696.04 Mn | -93.52 Mn |
| 7 | Illumina | 29.90 Bn | 28.73 Bn | 770.00 Mn | 245.00 Mn |
| 8 | Mettler Toledo International | 28.58 Bn | 28.53 Bn | 650.22 Mn | 328.45 Mn |
| 9 | Quest Diagnostics | 26.18 Bn | 25.55 Bn | 1.03 Bn | 459.00 Mn |
| 10 | Neogenomics | 2.07 Bn | 1.92 Bn | 91.88 Mn | -9.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.77 Mn |
| Mar 31, 2026 | -18.24 Mn |
| Dec 31, 2025 | -13.41 Mn |
| Sep 30, 2025 | -27.01 Mn |
| Jun 30, 2025 | -47.63 Mn |
| Mar 31, 2025 | -27.83 Mn |
| Dec 31, 2024 | -18.40 Mn |
| Sep 30, 2024 | -21.20 Mn |
| Jun 30, 2024 | -21.94 Mn |
| Mar 31, 2024 | -30.57 Mn |
| Dec 31, 2023 | -18.57 Mn |
| Sep 30, 2023 | -24.20 Mn |
| Jun 30, 2023 | -29.89 Mn |
| Mar 31, 2023 | -35.07 Mn |
| Dec 31, 2022 | -26.38 Mn |
| Sep 30, 2022 | -39.51 Mn |
| Jun 30, 2022 | -39.70 Mn |
| Mar 31, 2022 | -52.03 Mn |
| Dec 31, 2021 | -41.57 Mn |
| Sep 30, 2021 | -39.71 Mn |